VANCOUVER, BC and LAS VEGAS, NV / ACCESSWIRE / April 11, 2024 / (CSE:OVAT)(OTCQB:OVATF) – Ovation Science Inc. (“Ovation” or the “Company”), with its patented topical and transdermal cannabis products powered by its skin delivery technology Invisicare®, is pleased to announce the signing of an exclusive licensing agreement for Ovation’s products for Canada with Ripco Processing Inc. (“Ripco”); a company based in Calgary, Alberta and founded by successful legal cannabis pioneers. Ripco is focused on the Canadian market where the demand for cannabis products is strong at an estimated $2.6 billion annually.
Under the terms of the License Agreement, Ripco will be responsible for all regulatory, manufacturing, marketing, sales and distribution activities for Ovation’s formulations through-out Canada, starting initially in Ontario, Alberta, BC, Saskatchewan and Manitoba. Ovation will receive a double-digit royalty based on sales, with a…
